Co-treatment with vactosertib, a novel, orally bioavailable activin receptor-like kinase 5 inhibitor, suppresses radiotherapy-induced epithelial-to-mesenchymal transition, cancer cell stemness, and lung metastasis of breast cancer
, , and
Apr 07, 2022
About this article
Article Category: Research Article
Published Online: Apr 07, 2022
Page range: 185 - 197
Received: Sep 26, 2021
Accepted: Jan 28, 2022
DOI: https://doi.org/10.2478/raon-2022-0012
Keywords
© 2022 Jiwon Choi, Jiyoung Park, Ilyoung Cho, Yhunyhong Sheen, published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
Choi, Jiwon
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Park, Jiyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
National Center for Efficacy Evaluation for Respiratory Disease Products, Korea Institute of ToxicologySeoul, Republic of Korea
Cho, Ilyoung
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea
Sheen, Yhunyhong
College of Pharmacy, Ewha Womans UniversitySeoul, Republic of Korea